BGM Group Ltd. (NASDAQ:BGM) Stock Short Interest Report for October

BGM Group Ltd. (NASDAQ:BGM) saw a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 8,247 shares, a decline of 92.6% from the September 30th total of 112,147 shares. Based on an average trading volume of 11,701 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.2% of the shares of the company are sold short.

BGM Group Stock Performance

BGM traded up $0.57 on Tuesday, reaching $8.97. The company had a trading volume of 2,068 shares, compared to its average volume of 9,586. The company has a fifty day moving average of $8.42 and a 200-day moving average of $22.33. BGM Group has a one year low of $6.45 and a one year high of $302.40.

BGM Group (NASDAQ:BGM) last released its quarterly earnings results on Friday, August 28th. The company reported ($0.30) EPS for the quarter. The business had revenue of $12.15 million for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings cut BGM Group from a “sell (d)” rating to a “sell (e+)” rating in a research report on Thursday, August 6th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

About BGM Group

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.